A well-known pioneer in the industry of medical technologies and remote patient
monitoring services. As the founder of LifeWatch AG (former Card Guard AG and
Card Guard Scientific Survival Ltd.) he successfully led the company to an IPO. Up
until 2014, Dr. Geva was a member and the Chairman of the Board of Directors
and Corporate CEO of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a
Chief Mechanical Engineer with Vishay Israel – a subsidiary of Vishay
Intertechnology, USA. Dr. Geva holds a B.Sc in Mechanical and Nuclear
Engineering, a Ph.D. (with honours) in Business Administration from the
International School of Management, Paris and an honorary doctorate from
Oxford Brooks University. Dr. Geva is also a senior member of the royal society of
medicine in the UK (RSM).
Dr. Kenneth Melani has over 30 years’ experience in the health care industry as a
provider, supplier and insurer. He began his career in 1981 as a practicing
physician growing his internal medicine practice into the largest multi-specialty
physician practice in Western Pennsylvania. In the mid 1980’s he helped start a
physician hospital organisation, West Penn Cares, where he became the CEO. In
this role he prepared the Organisation for managed care risk sharing contracts
(known as ACO’s today). In addition, he started seven successful for-profit health
services businesses. In 1989 he joined Highmark Inc. (formerly known as Blue Cross
of Western Pennsylvania) where he spent the next 23 years of his career in a variety
of positions including Chief Medical Officer, President of Health Related Services,
and EVP, Strategy and New Business Development. In 2003, he was named the
President and CEO of Highmark Inc. During his nine and half year tenure he grew
the company into one of the largest and most diversified health care companies
in the United States, serving over 32 million individuals.
Professor Rotstein is an internationally recognised cardiologist and expert in health management systems, with decades of experience across consultancy and academia. Currently he serves as the Director General, Hadassah Medical Organization; Associate Clinical Professor, The Hebrew University of Jerusalem; Associate Clinical Professor, Sackler School of Medicine Tel Aviv University; and Associate Clinical Professor, The Hebrew University of Jerusalem. Professor Rostein has acted as an expert consultant in the construction of several medical facilities throughout the world including Centro Medico La Paz, Equatorial Guinea (major referral hospital in Equatorial Guinea), the Lagoon Hospital, Accra, Ghana and currently the Moscow Medical Cluster Oncological Centre and Polyclinic of Skolkovo, Moscow. Professor Rotstein trained in medicine at Tel Aviv University, and has held fellowships at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre School of Hygiene and Public Health.
Dr. Gleitman is the Chairman of the Guangzhuo Israel Biotech Fund, Chairman of
the Board of Directors of Capital Point Group, a Board member and Chairman of
the audit and financial committees of Elbit Systems (NASDAQ, TLV traded),
Chairman of the YoYa Group, Senior Advisor to the World Bank (national policy for
innovation) and Senior Strategy Advisor to Serbia Innovation Fund.
Prior to holding the positions set out above, Dr. Gleitman was the Chief Scientist
and Director General of Israel’s Ministry of Industry and Trade, where he managed
all of the Israeli Government technological programs. In the course of his four-year
tenure, Dr. Gleitman was responsible for allocating over $1.5 billion in grants in the
framework of promoting research and development activities in the Israeli hightech
Dr. Gleitman also served as the CEO of Ampal Investment Group (NASDAQ:
AMPL), where he was responsible for the investment of over $200 million in hightech
ventures. During his tenure at Ampal, Dr. Gleitman led a $330 million joint
venture with Motorola Israel founding Mirs Communications Ltd., Israel’s fourth
largest cellular operator.
Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in
Physical Chemistry, from the Hebrew University of Jerusalem.
Dr. Brendan de Kauwe has served on our board of directors since February 2017, and was the Company’s Corporate Advisor and Lead Manager to the Initial Public Offering (IPO) on the Australian Securities Exchange (ASX). Dr de Kauwe studied a Bachelor of Science in Pharmacology and Physiology and holds a Bachelor of Dental Surgery from the University of Western Australia, with Post Graduate certifications in Oral Surgery and Implantology. He also holds a Post Graduate Diploma in Applied Finance, majoring in Corporate Finance, and is an Australian Securities and Investments Commission complaint (RG146) Securities Advisor. Dr de Kauwe is an experienced operations and transaction focused executive with key skills in creating company value through strategic partnerships and mergers and acquisitions, with particular experience in the biotechnology, life sciences and technology sectors. He is also a Director of a private investment banking firm with vast experience in corporate restructuring and recapitalisations, mergers and acquisitions, as well as public market transactions and equity capital markets in both Australia and internationally. Dr de Kauwe has served as Chairman and/or Director of numerous ASX listed companies.
Mr Wettstein, citizen of Switzerland, was an advisor and investor in numerous pre-
IPO investments since 1985 and was instrumental for several successful IPO’s in
Switzerland. He operated his own accounting, auditing and tax consultancy firm
in Zurich, Switzerland from 1983 to 2007. From 1976 to 1982, he was an auditor and
tax consultant with Coopers & Lybrand AG, Zurich. Urs Wettstein graduated as a
Certified Public Accountant. From 2001 to 2014 he served as non-executive Vice
Chairman of the Board of Directors of LifeWatch AG, a company listed on the
Swiss Stock Exchange.
Mr Heumann is a top operation and business executive with proven ability to drive
efficiency and business value. Mr. Heumann brings with him advanced skills in
strategic planning, international negotiations and business development. Mr.
Heumann is a results-oriented leader with extensive experience in directing
complex projects. His expertise in streamlining efficiencies demonstrated great
success in reducing costs to the value of millions of dollars in his past roles as COO
in the US. He has more than 20 years’ experience in Hi-Tech, mHealth, operations
and services industries, helped with building high performance teams, and
managed multi-billion dollar budgets. Mr. Heumann attained his business
management education from Bar-Ilan University, Israel.
Mr Ben-Efraim is an experienced, senior CFO of global companies with more than
20 years’ experience in the finance and accounting domain. Mr. Ben-Efraim has
served in Israeli high tech companies like DSPC Group (a NASDAQ-traded
company), where he held a number of positions, including Chief Accountant of
the group, and El-Op where he was Deputy Controller in charge of tax and
accounting. From 2003, Mr. Ben-Efraim served as the Corporate CFO in a global
medical devices manufacturer and services provider company, where amongst
other things, he was in charge, of the cash flow management, annual budget
approvals, financial reporting to the stock exchange and analysts corporate
presentations. Mr. Ben-Efraim holds a B.A in Economics and Accounting from Tel
Aviv University, and is a Certified Public Accountant (IL).
Mr Geva has more than 17 years’ of experience in the Hi-Tech and medical
device industry, and as the former CTO and Strategic Projects Manager at
Lifewatch Technologies, Nir brings with him a broad knowledge on products
definition and development, project management and manufacturing of
medical devices. Nir has a strong development and manufacturing global
network and a deep understanding of the business culture. Nir has also been
involved in projects in the fields of mobile apps and IoT and wrote over 15 patents
related to medical devices, remote patients monitoring and IoT. Nir holds a BSc.
In Mechanical Engineering from the Technion in Haifa and an Executive MBA from
Kellogg School of Management (Northwestern University in Chicago).
Merger & Acquisition
Over 25 years of international business and banking experience and an extensive global network in which he oversaw several multi-million global deals. Held senior executive positions including Head of the Israeli branch of Crédit Agricole Corporate and Investment Bank, following hands-on experience in investment banking in Paris and private banking in Switzerland; Senior Country Officer in Israel of one of the top ten global banks; Senior Partner in one of the Israel’s leading law firms. Mr. Shahar is qualified as a lawyer and as a Notary and is a member of the Israel Bar Association. His fields of expertise are banking and international investments, mergers & acquisitions and international contracts.
Mr. Marom joined G Medical in 2017, and has focused on establishing our operations in China, including setting up the manufacturing facility, managing vendors, recruiting employees, managing the CFDA approval process, and pursuing business development. Mr. Marom brings years of experience in international business development in Europe, Asia and Africa where he developed and led activities in technological and industrial sectors and helped lay the foundation for joint projects in energy and agriculture. He also represented one of Europe’s largest cellular logistics and equipment vendors in Israel. Prior to this, Mr. Marom held senior management and professional positions as a civil servant in the Israeli government. He has a B.A in Social Sciences from Bar Ilan University, Israel.